Results 91 to 100 of about 93,843 (327)

Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Liver disease constitutes a significant global health concern, particularly in China where it has distinctive characteristics. China grapples with a staggering 300 million cases, predominantly due to hepatitis B and metabolic non‐alcoholic fatty liver disease. Additionally, hepatocellular carcinoma has become a prevalent which is a lethal type
Feng Zhang   +5 more
wiley   +1 more source

Point Prevalence of Hepatitis B Virus Infection among Adolescents in Visakhapatnam, India

open access: yesJournal of Medical Microbiology and Infectious Diseases, 2015
Introduction: Occurrence of detectable amounts of viral antigen or viral particles in the blood of infected patients with Hepatitis B virus (HBV) is a significant characteristic of HBV infection. Detection of HBV antigen or its DNA among individuals of a
Vijayalakshmi Payala   +2 more
doaj  

Frequency of Anti-HCV, HBsAg, HIV1-p24 Antigen, Acid Fast Bacilli and Plasmodium spp., in Herbal Home and Hospital Patients with Elevated TNFα (≥ 5.0 pg/ml) in Saki, West Nigeria

open access: yesJournal of Pure and Applied Microbiology, 2019
Infectious agents and chemical substances can trigger the production and the release of cytokines. To determine the pattern of infectious agents in herbal homes patients with elevated TNFα (≥ 5.0 pg/ml) in Saki – West-Nigeria.
Mathew Folaranmi Olaniyan   +1 more
doaj   +1 more source

A sensitive single reverse passive haemagglutination test for detecting both HBsAg and anti-HBs. [PDF]

open access: bronze, 1979
J. A. J. Barbara   +6 more
openalex   +1 more source

SHBs Mitigates Sorafenib‐Induced Apoptosis in Hepatocellular Carcinoma via Activation of RAF1/MEK/ERK Signaling Pathway

open access: yesCancer Science, EarlyView.
Hepatitis B virus (HBV) infection is a major driver of hepatocellular carcinoma (HCC) and is associated with resistance to sorafenib, the first‐line treatment for advanced HCC. This study demonstrates that the small HBV surface antigen (SHBs) promotes sorafenib resistance by activating the RAF1/MEK/ERK signaling pathway, inhibiting apoptosis in HCC ...
Shuxiang Wu   +6 more
wiley   +1 more source

Role of HBsAg Neutralisation Test in Low Positive and Indeterminate HBsAg Results by Electrochemiluminescence

open access: yesJournal of Pure and Applied Microbiology
Hepatitis B surface antigen (HBsAg) is the important marker in diagnosis and decision making of Hepatitis B infection. Equivocal results are common diagnostic challenges with HBsAg.
Mridula Madiyal   +2 more
doaj   +1 more source

The prevalence of HBsAg among pregnant women referred to Kerman maternity hospitals in 1997 [PDF]

open access: yesJournal of Kerman University of Medical Sciences, 1999
Hepatitis B virus(HBV) is potentialy ba serious and lethal oathogen causing a wide range of diseases such as :fulminant hepatitis,cirrhisis,chronic active hepatitis,and hepatocellular carcinoma.moreover 5-10% of infected adults and 70-90% of infected ...
B.SH Ali
doaj  

Vaccination in Multiple Myeloma: Challenges and Strategies

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Background Multiple myeloma (MM) is a hematological malignancy characterized by profound immunosuppression resulting from both disease‐related mechanisms and treatment‐induced immune dysfunction. This compromised immune status markedly increases susceptibility to infections, a leading cause of morbidity and mortality in MM patients.
Enrica Antonia Martino   +10 more
wiley   +1 more source

Liver Cirrhosis Secondary to Overlap Autoimmune Liver Disease as the Initial Presentation of Sjögren's Syndrome

open access: yes
Portal Hypertension &Cirrhosis, EarlyView.
Saikrishna R. Bana   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy